We are live on ! Find out more
AIIC

AJU IB Investment Company Portfolio holdings

AUM $30.5M
1-Year Est. Return 128.96%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+128.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$51.6M
AUM Growth
-$13.1M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$25M 48.34%
1,380,890
KYMR icon
2
Kymera Therapeutics
KYMR
$8.94B
$9M 17.42%
457,059
SEER icon
3
Seer Inc
SEER
$120M
$7.31M 14.15%
816,375
RLYB icon
4
Rallybio
RLYB
$85.8M
$5.7M 11.03%
94,335
XLO icon
5
Xilio Therapeutics
XLO
$60.3M
$1.95M 3.78%
47,696
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$1.82M 3.52%
12,438
STRO icon
7
Sutro Biopharma
STRO
$421M
$912K 1.77%
17,500

Similar funds

AJU IB Investment Company's Q2 2022 Portfolio in Review

As of Q2 2022, AJU IB Investment Company held 7 positions worth $51.6M, down 20% from $64.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. AJU IB Investment Company opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AJU IB Investment Company's ten largest holdings make up 100% of its $51.6M portfolio in Q2 2022.
  • AJU IB Investment Company opened 0 new positions and closed 0 in Q2 2022.
  • AJU IB Investment Company's portfolio value fell 20% quarter-over-quarter to $51.6M.

Based on AJU IB Investment Company's 13F filing for Q2 2022, filed 9 Aug 2022.